| Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients | 2006/10/01 | English | 126 |
| Safety and Tolerability of the Lidocaine Patch 5%, a Targeted Peripheral Analgesic: A Review of the Literature | 2003/02/01 | English | 125 |
| The Contribution of P‐glycoprotein to Pharmacokinetic Drug‐Drug Interactions | 1999/12/01 | English | 124 |
| Review: Drug Therapy in Chinese Traditional Medicine | 2000/05/01 | English | 123 |
| A Double‐Blind, Placebo‐Controlled, Ascending‐Dose Evaluation of the Pharmacokinetics and Tolerability of Modafinil Tablets in Healthy Male Volunteers | 1999/01/01 | English | 122 |
| The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers | 2011/12/01 | English | 121 |
| Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Subjects and Patients with Noninsulin‐Dependent Diabetes Mellitus | 1996/11/01 | English | 121 |
| Pharmacokinetics of Micafungin in Healthy Volunteers, Volunteers With Moderate Liver Disease, and Volunteers With Renal Dysfunction | 2005/10/01 | English | 121 |
| Clinical Utility of Monitoring Tacrolimus Blood Concentrations in Liver Transplant Patients | 2001/05/01 | English | 121 |
| Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment | 2008/12/01 | English | 121 |
| Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban | 2015/12/04 | English | 120 |
| Pharmacokinetics of Fluvastatin After Single and Multiple Doses in Normal Volunteers | 1992/07/01 | English | 120 |
| The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function | 2003/02/01 | English | 119 |
| Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic‐derived dose justification for phase 3 studies in patients with nosocomial pneumonia | 2015/08/25 | English | 119 |
| Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron‐Chelating Agent in Patients with Transfusion‐Dependent Iron Overload Due to β‐Thalassemia | 2003/06/01 | English | 118 |
| Absolute Bioavailability of Imatinib (Glivec®) Orally versus Intravenous Infusion | 2004/02/01 | English | 118 |
| Probiotics in Disease Prevention and Treatment | 2018/09/24 | English | 118 |
| Pharmacokinetics and Pharmacodynamics of a Bolus and Infusion of Cangrelor: A Direct, Parenteral P2Y12 Receptor Antagonist | 2010/01/01 | English | 116 |
| Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP‐4 Inhibitor Sitagliptin in Middle‐Aged Obese Subjects | 2006/08/01 | English | 116 |
| Dose Equivalency Evaluation of Major Corticosteroids: Pharmacokinetics and Cell Trafficking and Cortisol Dynamics | 2003/11/01 | English | 115 |
| The Clinical Pharmacokinetics of Phosphodiesterase‐5 Inhibitors for Erectile Dysfunction | 2005/09/01 | English | 115 |
| Clinical Pharmacology of Rasagiline: A Novel, Second‐Generation Propargylamine for the Treatment of Parkinson Disease | 2005/08/01 | English | 114 |
| The Effect of Renal Insufficiency on Mycophenolic Acid Protein Binding | 1999/07/01 | English | 114 |
| Efficacy of Dichloroacetate as a Lactate‐Lowering Drug | 2003/07/01 | English | 114 |
| Interaction of Warfarin With Drugs, Natural Substances, and Foods | 2005/02/01 | English | 114 |
| Five Distinct Human Cytochromes Mediate Amitriptyline N‐Demethylation In Vitro: Dominance of CYP 2C19 and 3A4 | 1998/02/01 | English | 113 |
| Rheumatoid Arthritis: An Overview of New and Emerging Therapies | 2005/07/01 | English | 113 |
| Bioavailability of Sublingual Buprenorphine | 1997/01/01 | English | 113 |
| Systemic Availability and Pharmacokinetics of Thymol in Humans | 2002/07/01 | English | 113 |
| The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg | 1988/07/01 | English | 112 |